One common question is about the safety and efficacy of these injections
In animal and preliminary human studies, BPC 157 showed the ability to: Accelerate regeneration of muscles, tendons, and ligaments Support brain and nervous system function Influence the lining of the gut Reduce inflammation markers Support sleep quality Enhance mood and mental clarity Promote blood vessel formation in injured tissues Support bone density and connective tissue integrity All of this from something born in the stomach
What stood out: CagriSema achieved 23.0% weight loss at 84 weeks (efficacy estimand) Tirzepatide achieved 25.5% On the treatment-regimen estimand, weight loss was 20.2% vs 23.6% Primary endpoint not met: CagriSema did not demonstrate non-inferiority vs tirzepatide on weight loss at 84 weeks Why this matters This is a reminder that in obesity pharmacotherapy, very effective and best-in-class are not the same conversation
These peptides can naturally occur in the body, but when used in therapy, they are synthetically produced to support functions like fat breakdown, muscle growth, collagen production, and even immune system enhancement
